Evercore HC Menlo vs Lazard HC SF
Curious on how these two groups stack up against one another in terms of deal flow, culture, pay, and overall the better place to work (objectively).
Curious on how these two groups stack up against one another in terms of deal flow, culture, pay, and overall the better place to work (objectively).
| +355 | Evercore Intern Seizure | 54 | 7h |
| +67 | JPM M&A is Gone??? Purely Coverage Banking??? | 31 | 6h |
| +58 | Is DCM actually underrated ? | 24 | 17h |
| +50 | How do I understand vs. just memorizing? | 5 | 16h |
| +48 | Losing my personality in Banking | 9 | 17h |
| +47 | Are all Tech / TMT groups sweaty? | 38 | 13h |
| +42 | Associate & Above IB exits | 16 | 3d |
| +32 | Incoming IB Analyst: Best Ways to Prepare? | 10 | 9h |
| +27 | Which groups are ideal for laterals? | 12 | 11h |
| +24 | The good and bad with Wells Fargo | 1 | 17h |
Career Resources
evercore pays more, is much better in terms of dealflow (lowk evercore is top 2 after poaching ben carpenter from JPM) and Laz only had 1 M&A pharma deal in 2025 (and the MD who brought that deal in j left for Leerink M&A), Laz probs has better culture (WFH monday and friday, people are all great). If you are optimizing for a great time pick Laz, if you are optimizing for deal flow, comp, and exits, def go evercore (only better shop is CVP and maybe GS).
Fuck California come to NYC like a real man
If I were in your shoes and had offers from both, I’d take Evercore Menlo over Lazard SF. Not just for the stronger M&A deal flow, but because the Evercore platform in biopharma feels like it has more momentum right now given the mandates they’ve been landing and the overall trajectory of the group with some of the recent hires they've made. You also get the added bonus of getting some capital markets exposure since Evercore’s team is occasionally involved on some impactful IPOs and follow-ons/PIPEs, which I'd argue is important if you possibly want to go down the VC route.
I go more into detail here in case you're interested: [Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC) | Wall Street Oasis
Voluptatem sapiente dolores et esse similique. Minima fugiat cupiditate architecto minima est. Error dignissimos est natus vel.
Suscipit molestiae reprehenderit praesentium ea distinctio eos. Tempora voluptatem ipsa qui laboriosam repellendus sed qui. Ab suscipit molestiae ipsam dolores. Maiores quam error repellendus quo id. Harum incidunt aperiam praesentium reiciendis aut deleniti. Qui delectus voluptatem omnis culpa rerum quas ea.
Repellat enim quaerat omnis velit alias totam suscipit. Ut consequatur et asperiores accusamus est minima consequuntur et.
Et non accusantium velit ex. Voluptas iste quia molestiae consequuntur similique. Dignissimos ut dignissimos recusandae unde. Itaque nemo tempore optio amet suscipit.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...